Global Pharmaceutical Contract Manufacturing Market 2016: Industry Review, Insights, Demand and Analysis to 2022

Global Market Research Report on Pharmaceutical Contract Manufacturing Market 2016 is a professional and in-depth complete study on the current state of the Pharmaceutical Contract Manufacturing worldwide.

Logo

Deerfield Beach, FL -- (SBWire) -- 09/20/2016 --The global market for pharmaceutical contract manufacturing represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly to the overall outsourcing market, owing to its popularity and widespread adoption by pharmaceutical companies. Cost containment issues resulted from global economic constraints, have exerted extensive pressure on pharmaceutical manufacturers to reduce the cost of products. Hence, to make way out of this situation, pharma companies are looking to reduce the manufacturing cost.

Contract manufacturing, as a strategic option, offers the certain benefits such as cost reduction, improved product quality, product portfolio and reduction in time to market. Contract manufacturing also support the pharmaceutical companies to focus on R&D and marketing activities by minimizing the time and efforts invested in manufacturing activity. Hence, contract manufacturing is the largely accepted trend in the recent years. HAUPT Pharma AG, Abbott Laboratories, NextPharma, Catalent Pharma Solutions, Althea Technologies, Jubilant Life Sciences Limited, Royal DSM N.V and Nipro Corp. are some of the big players of this market. Patent expiration of major therapeutic brands, growing demand for generic drugs and adoption of novel manufacturing technologies are expected to boost the growth of this market.

Get Free Sample Report Of Pharmaceutical Contract Manufacturing Market :http://www.marketresearchstore.com/report/world-pharmaceutical-contract-manufacturing-market-opportunities-and-68539#RequestSample

The global market for pharmaceutical contract manufacturing is segmented based on type of contract manufacturing and geography. Based on type of contract manufacturing, the market is segmented as, Active Pharmaceutical Ingredients (API) / Bulk drug, Final Dosage Form (FDF), advanced drug delivery products, OTC medicines and Nutritional products and Packaging contract manufacturing. The final dosage form contract manufacturing (FDF) is expected to grow with substantial CAGR due to growing demand for generic products and rising R&D investments.

Geographically, global market for pharmaceutical contract manufacturing is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global contract manufacturing market, whereas, Asia-Pacific is the fastest growing market due to adoption of advanced technologies, favorable regulatory framework, reduced labor cost and availability of skilled workforce.

Do Inquiry Before Purchasing Report:http://www.marketresearchstore.com/report/world-pharmaceutical-contract-manufacturing-market-opportunities-and-68539#InquiryForBuying

KEY BENEFITS

This report offers the following benefits in particular:

In-depth coverage of drivers, restraints and opportunities within global market for pharmaceutical contract manufacturing would help professionals to better understand market behavior.

Porter's Five Forces analysis examines the competitive structure of the global market for pharmaceutical contract manufacturing and would assist market strategists in their respective decision making process.

Pin-point analysis of geographic segments helps to identify opportunities for growth within the global market for pharmaceutical contract manufacturing.

Deep insights on key developments and regulatory framework of global market for pharmaceutical contract manufacturing would be informative for professionals in corporate sector .

KEY MARKET SEGMENTS

The global market for pharmaceutical contract manufacturing is segmented into two major categories such as, type and geography.

MARKET BY DRUG TYPE

Active Pharmaceutical Ingredients (API) / Bulk drug
Final Dosage Form (FDF)
Solid dosage form
Semi-solid dosage form
Liquid dosage form
Advanced drug delivery products
OTC medicines and Nutritional products
Packaging

MARKET BY GEOGRAPHY

North America
Europe
Asia-Pacific
LAMEA

About Market Research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Joel John
3422 SW 15 Street, Suite #8138,
Deerfield Beach, Florida 33442,
United States
Tel: 386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/

Media Relations Contact

Nicole Austin
Corporate Sales Specialist
Market Research Store
855-465-4651
http://www.marketresearchstore.com/report/world-pharmaceutical-contract-manufacturing-market-opportunities-and-68539

View this press release online at: http://rwire.com/724666